静脉血栓栓塞症（VTE）的形成机制及其预防研究现状-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

静脉血栓栓塞症（VTE）的形成机制及其预防研究现状

The formation mechanism of venous thromboembolism (VTE) and the current status of its prevention

ES评分 0 浏览量：45 下载量：0

DOI	10.12208/j.ijcr.20250282
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2025, 9(6)
作者	伊鑫¹,李海峰^1,2*,
作者单位	1 大理大学临床医学院云南大理,2 大理大学第二附属医院云南昆明
摘要	静脉血栓栓塞症（VTE）包括深静脉血栓形成（DVT）和肺栓塞（PE），是一种高发病率、高致死率的血栓性疾病。其发病机制涉及血液成分异常、血管内皮损伤、炎症-免疫激活及遗传易感性等，多种因素交互作用导致凝血-纤溶失衡。目前预防策略基于风险评估，以机械和药物预防为核心。未来研究将聚焦于构建多维度风险预测模型与精准分层干预，以降低VTE的疾病负担。
Abstract	Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a highly prevalent and lethal thrombotic disease. Its pathogenesis involves abnormalities in blood components, endothelial damage, inflammatory-immune activation, and genetic susceptibility, with multiple factors interacting to lead to coagulation-fibrinolytic imbalance. Current prevention strategies are based on risk assessment, with mechanical and pharmacological interventions at the core. Future research will focus on developing multidimensional risk prediction models and precise stratified interventions to reduce the burden of VTE.
关键词	静脉血栓栓塞症；形成机制；风险评估；预防策略
KeyWord	Venous thromboembolism; Mechanism of formation; Risk assessment; Prevention strategies
基金项目
页码	57-60

参考文献
相关文献

[1] 崔咏诗,邓莉,彭礼飞.静脉血栓栓塞症抗凝靶点的研究现状与前景
[J].实用心脑肺血管病杂志,2023,31(04):1-7.
[2] Zhen K, Tao Y, Xia L, et al. Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study
[published correction appears in Lancet Reg Health West Pac. 2025 Jan 16;54:101472.
[3] Najem MY, Couturaud F, Lemarié CA. Cytokine and chemokine regulation of venous thromboembolism. J Thromb Haemost. 2020;18(5):1009-1019.
[4] Abuduhalike R, Abudouwayiti A, Juan S, MaheMuti A. Study on the Mechanism of NLRP3/IL-1/ NF-κB Signaling Pathway and Macrophage Polarization in the Occurrence and Development of VTE. Ann Vasc Surg. 2023;89:280-292.
[5] Zapponi KCS, Orsi FA, Cunha JLR, et al. Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event. J Thromb Thrombolysis. 2022;53(1):30-42.
[6] Yao M, Ma J, Wu D, et al. Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy. Front Immunol. 2023;14:1198952. Published 2023 Aug 23.
[7] Navarrete S, Solar C, Tapia R, Pereira J, Fuentes E, Palomo I. Pathophysiology of deep vein thrombosis.Clin Exp Med. 2023;23(3):645-654.
[8] Schulman S, Makatsariya A, Khizroeva J, Bitsadze V, Kapanadze D. The Basic Principles of Pathophysiology of Venous Thrombosis.Int J Mol Sci. 2024;25(21):11447. Published 2024 Oct 24.
[9] Zifkos K, Dubois C, Schäfer K. Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence. Int J Mol Sci. 2021;22(17):9317. Published 2021 Aug 27.
[10] 李孝成,陈俞宏,韦征霞.微小RNA-150及靶基因SRC激酶信号抑制剂1在下肢深静脉血栓中的表达及作用机制
[J].血管与腔内血管外科杂志,2024,10(03):338-344.
[11] Fang C, Huang F, Yao M, et al. Advances in microRNA regulation of deep vein thrombosis through venous vascular endothelial cells (Review). Mol Med Rep. 2024;29(6):96.
[12] 彭玲,周超.循环微RNA参与静脉血栓栓塞的形成机制及其诊断价值
[J].上海医学,2020,43(10):628-633.
[13] 李磊,袁启东,彭喜涛,等.microRNA在深静脉血栓形成领域中的研究进展
[J].中国比较医学杂志,2024,34(11):169-176.
[14] Wang R, Tang LV, Hu Y. Genetic factors, risk prediction and AI application of thrombotic diseases. Exp Hematol Oncol. 2024;13(1):89. Published 2024 Aug 27.
[15] 张建军,靳志雄,胡常晖,等.PAI-1基因多态性与血小板聚集率交互作用对下肢深静脉血栓形成的影响
[J].现代检验医学杂志,2023,38(06):48-53.
[16] Bezerra OCL, Rodger M, Munsch G, et al. Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism. J Thromb Haemost. Published online January 21, 2025.
[17] Westin IM, Landfors M, Giannopoulos A, et al. DNA methylation changes and increased mRNA expression of coagulation proteins, factor V and thrombomodulin in Fuchs endothelial corneal dystrophy. Cell Mol Life Sci. 2023;80(3):62. Published 2023 Feb 11.
[18] 李蓉,张静,杨鑫.基于Khorana评分改良的癌症患者并发静脉血栓评估工具
[J].护理学杂志,2023,38(12):25-29.
[19] Duffett L. Deep Venous Thrombosis. Ann Intern Med. 2022;175(9):ITC129-ITC144.
[20] Birchansky J, Frishman WH. Milvexian: A Focus on a New Oral Anticoagulant that Targets Factor XIa for Thromboembolism Prophylaxis. Cardiol Rev. 2025;33(1):93-97.

引用本文

伊鑫,李海峰^,*. 静脉血栓栓塞症（VTE）的形成机制及其预防研究现状 [J]. 国际临床研究杂志. 2025; 9; (6). 57 - 60.

文献评论

相关学者

相关机构